Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BANSAR for smoking cessation in expectant fathers
NCT03671707Completed
- Sponsor
- The University of Hong Kong
- Start
- Oct 2018
- Primary completion
- Oct 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Biochemically-validated abstinence at 6 months. Started Oct 2018; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03671707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671707.